Dr Aqorau highlights mental issue, pleas for gov’t’s urgent intervention as drug runs out of stock

Vice Chancellor of the Solomon Islands National University Dr. Transform Aqorau has expressed serious concern on the severe shortage of modicate  a crucial injectable medication used to treat patients with acute psychosis which has been out of stock.

Speaking at SIG-Donors Round table yesterday in Honiara, Dr. Aqorau says the links between health and development cannot be overstated.

“A healthy population is a productive population, capable of driving economic growth. To that end, we must invest in preventive healthcare, ensuring that the rural population has access to basic health services, clean water, and sanitation. Improving healthcare infrastructure and workforce capacity must be prioritised to strengthen the health sector,” said the VC.

Dr Aqorau added: “When we speak of health as a pillar of human development, we cannot overlook the critical and often neglected issue of mental health.”

He said mental health challenges in the Solomon Islands are pervasive, yet they remain under-recognised and under-resourced.

“On a personal level, I have witnessed the profound effects of alienation and disenfranchisement that individuals and families experience when a loved one suffers from mental illness. This sense of isolation is deepened by the limited support structures available, and the stigma that still surrounds mental health issues in our communities,” he said.

Dr Aqorau pointed out that one of the most pressing concerns in our mental health sector is the severe shortage of essential medication. In particular, “Modicate”, a crucial injectable medication used to treat patients with acute psychosis, has been out of stock.

“This medication is vital for managing individuals who suffer from severe mental health episodes, where the risk of violent behaviour can be high. The absence of this critical drug is deeply alarming, as it makes the difference between stabilising a patient in crisis and exposing them, their families, and the community to significant risks,” said the VC.

He underscored:  “That the lack of “Modicate” has heightened our apprehension as we face growing challenges in managing acute cases of psychosis, which require immediate and effective intervention. The shortage not only impacts the ability of healthcare professionals to administer proper care but also leaves families in fear and uncertainty about the safety and well-being of their loved ones. The implications are serious, as untreated acute psychosis can result in unpredictable and dangerous behaviours that put both the patients and others at risk.”

Establishment of a Solomon Islands Mental Health Foundation

In response to these concerns, Dr. Aqorau said: “Some of us are working towards the establishment of a Solomon Islands Mental Health Foundation. This foundation aims to address the gaps in mental health services and advocate for the resources necessary to support those affected by mental illness.”

 However, he admitted this is only a starting point.

“I make a special appeal to the Government and to our donor partners to take immediate action by securing an emergency supply of “Modicate” and other essential medications for mental health patients. This is not just about healthcare; it is about safeguarding lives, preventing crises, and ensuring that mental health is treated with the seriousness it deserves in our development agenda,” said Dr Aqorau. He added: “Without swift intervention, we are left vulnerable to the risks that arise from untreated mental health crises. The Solomon Islands cannot afford to turn a blind eye to this growing public health issue. I urge all stakeholders to prioritise mental health as a critical component of our national development and to work collectively to ensure that no family, no individual, faces these challenges alone.”